These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 30605742

  • 1. Genetic Profiling of Primary Orbital Melanoma: An Analysis of 6 Cases with Clinicopathologic Correlation.
    Mudhar HS, Doherty RE, Salvi SM, Currie ZI, Tan JH, Sisley K.
    Ophthalmology; 2019 Jul; 126(7):1045-1052. PubMed ID: 30605742
    [Abstract] [Full Text] [Related]

  • 2. Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.
    Rose AM, Luo R, Radia UK, Kalirai H, Thornton S, Luthert PJ, Jayasena CN, Verity DH, Coupland SE, Rose GE.
    BMC Cancer; 2018 Dec 17; 18(1):1262. PubMed ID: 30558566
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
    van Poppelen NM, Vaarwater J, Mudhar HS, Sisley K, Rennie IG, Rundle P, Brands T, van den Bosch QCC, Mensink HW, de Klein A, Kiliç E, Verdijk RM.
    Ophthalmology; 2018 Jun 17; 125(6):904-912. PubMed ID: 29371009
    [Abstract] [Full Text] [Related]

  • 7. Uveal Melanomas with SF3B1 Mutations: A Distinct Subclass Associated with Late-Onset Metastases.
    Yavuzyigitoglu S, Koopmans AE, Verdijk RM, Vaarwater J, Eussen B, van Bodegom A, Paridaens D, Kiliç E, de Klein A, Rotterdam Ocular Melanoma Study Group.
    Ophthalmology; 2016 May 17; 123(5):1118-28. PubMed ID: 26923342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF.
    Ophthalmic Genet; 2021 Dec 17; 42(6):732-743. PubMed ID: 34353217
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S, Maric I, Rutigliani M, Lanza F, Puntoni M, Banelli B, Rancati S, Angelini G, Amaro A, Ligorio P, Defferrari C, Castagnetta M, Bandelloni R, Mosci C, DeCensi A, Romani M, Pfeffer U, Viaggi S, Coviello DA.
    Genes Chromosomes Cancer; 2018 Aug 17; 57(8):387-400. PubMed ID: 29689622
    [Abstract] [Full Text] [Related]

  • 11. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
    Isaacson AL, Sompallae RR, Guseva NV, Bellizzi AM, Bossler AD, Ma D.
    Am J Clin Pathol; 2022 Aug 04; 158(2):177-186. PubMed ID: 35212356
    [Abstract] [Full Text] [Related]

  • 12. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG, Koopmans AE, Vaarwater J, Verdijk RM, de Klein A, Naus NC, Kiliç E.
    Melanoma Res; 2015 Oct 04; 25(5):447-9. PubMed ID: 26086698
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM, Gravdal K, Mørk SJ, Heegaard S, Vintermyr OK, Krohn J.
    Acta Ophthalmol; 2018 Feb 04; 96(1):31-38. PubMed ID: 28444874
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J, Gessi M, Sucker A, Möller I, Stiller M, Horn S, Scholz SL, Pischler C, Stadtler N, Schilling B, Zimmer L, Hillen U, Scolyer RA, Buckland ME, Lauriola L, Pietsch T, Waha A, Schadendorf D, Murali R, Griewank KG.
    J Neurooncol; 2016 May 04; 127(3):435-44. PubMed ID: 26744134
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.